Patent: 9,969,724
✉ Email this page to a colleague
Summary for Patent: 9,969,724
| Title: | Factor IXa inhibitors |
| Abstract: | In its many embodiments, the present invention provides a novel class of benzamide compounds represented by Formula (I) or pharmaceutically acceptable salts or solvates thereof, or pharmaceutical compositions comprising one or more said compounds or pharmaceutically acceptable salts or solvates thereof, and methods for using said compounds or pharmaceutically acceptable salts or solvates thereof for treating or preventing a thromboses, embolisms, hypercoagulability or fibrotic changes. ##STR00001## |
| Inventor(s): | Sakurada; Isao (Tokyo, JP), Hirabayashi; Tomokazu (Tokyo, JP), Maeda; Yoshitaka (Tokyo, JP), Nagasue; Hiroshi (Tokyo, JP), Mizuno; Takashi (Tokyo, JP), Xu; Jiayi (Marlboro, NJ), Zhang; Ting (Princeton Junction, NJ), Smith; Cameron (Montgomery Village, MD), Parker; Dann (Cranford, NJ) |
| Assignee: | Merck Sharp & Dohme Corp. (Rahway, NJ) Mochida Pharmaceutical Co., Ltd. (Tokyo, JP) |
| Application Number: | 15/303,310 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,969,724
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | TRASYLOL | aprotinin | Injection | 020304 | 12/29/1993 | ⤷ Try a Trial | 2034-04-16 |
| Microbix Biosystems Inc. | KINLYTIC | urokinase | For Injection | 021846 | 01/16/1978 | ⤷ Try a Trial | 2034-04-16 |
| Genentech, Inc. | TNKASE | tenecteplase | For Injection | 103909 | 06/02/2000 | ⤷ Try a Trial | 2034-04-16 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
